Emla-Cream as Pain Relief During Pneumococcal Vaccination
Status:
Recruiting
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
The aim of this intervention study is to compare the efficacy of Emla cream as a pain relief
or no pain relief in connection to the first pneumococcal vaccination at the age of three
months in Child health care.
Primary objective
1.Leads Emla cream as pain relief to children in connection with pneumococcal vaccination at
the age of three months to lower pain scores in the use of FLACC as a pain measurement
instrument?
Phase:
N/A
Details
Lead Sponsor:
Beatrice Olsson Duse
Treatments:
EMLA Lidocaine Lidocaine, Prilocaine Drug Combination Prilocaine Vaccines